Alteration of methyldopa absorption, metabolism, and blood pressure control caused by ferrous sulfate and ferrous gluconate

Clinical Pharmacology and Therapeutics

Volumn 43, Issue 4, 1988, Pages 381-386

  Campbell, N ^a,b   Paddock, V ^a,b   Sundaram, R ^a,b  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^b Health Sciences Centre St John's   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FERROUS GLUCONATE; METHYLDOPA;

BLOOD PRESSURE; CLINICAL ARTICLE; DRUG ABSORPTION; DRUG INTERACTION; DRUG METABOLISM; DRUG PROTEIN BINDING; FEMALE; HUMAN; HUMAN EXPERIMENT; HYPERTENSION; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ADULT; AGED; BLOOD PRESSURE; DRUG INTERACTIONS; FEMALE; FERROUS COMPOUNDS; HUMAN; HYPERTENSION; INTESTINAL ABSORPTION; MALE; METHYLDOPA; RANDOM ALLOCATION; SUPPORT, NON-U.S. GOV'T;

EID: 0023901619     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.1988.47     Document Type: Article

References (14)